Skip to content

US health panel recommends easing restrictions on controversial peptides

World

Vote from advisory group – whose members include people linked to peptides industry – likely to embolden RFK Jr

A panel of federal health advisers on Thursday narrowly recommended easing access to several peptides popular with wellness influencers and celebrities, despite warnings from government scientists that the chemicals have not been shown to be safe or effective.

In a series of votes, outside experts to the Food and Drug Administration advised the agency to drop current restrictions barring pharmacies from producing injectable peptides with names like BPC-157, TB-500 and KPV.

Continue reading…


Source: The Guardian World — This article was automatically imported from the source. Read full article at original source →

TH
Originally published by The Guardian World theguardian.com
Visit original article

Gram Slattery

Leave a Comment